One in Five American Workers Tested Had a Positive Hair Drug Test in 2025, Signaling Persistent Long-Term Substance Use Patterns

{
  "signal_id": "175b4898-1de3-9660-992b-9de3d8394b99",
  "signal_type": "news",
  "signal_subtype": "launches",
  "detected_at": "2026-07-10T13:24:00+00:00",
  "company": {
    "name": "Quest Diagnostics",
    "domain": "questdiagnostics.com"
  },
  "data": {
    "url": "https://www.prnewswire.com/news-releases/one-in-five-american-workers-tested-had-a-positive-hair-drug-test-in-2025-signaling-persistent-long-term-substance-use-patterns-302822819.html",
    "title": "One in Five American Workers Tested Had a Positive Hair Drug Test in 2025, Signaling Persistent Long-Term Substance Use Patterns",
    "excerpt": "SECAUCUS, N.J. , July 10, 2026 /PRNewswire/ -- Nearly one in five workers in the general U.S. workforce (19.1%) tested positive for drug use based on an analysis of hair specimens collected in 2025, an increase of nearly 46% compared to 13.1% in 2021, finds the 2026 Quest Diagnostics Drug Testing Index™. For more information, visit www.QuestDiagnostics.com/DTI . Over the past five years, overall hair test positivity for marijuana increased 58.9% (9.5% in 2021 vs. 15.1% in 2025). Pre-employment hair test positivity for marijuana increased 49.5% over the past five years (10.1% in 2021 vs. 15.1% in 2025). Random hair test positivity for marijuana increased 14.8% in the same period (18.3% in 2021 vs. 21.0% in 2025). Marijuana also accounted for 52.5% of hair drug positives in 2025. By comparison, overall urine drug test positivity in the general U.S. workforce slightly declined to 4.3% in 2025 from 4.4% in the prior year. The findings suggest that a sizeable minority of the American workforce uses drugs, principally marijuana, on a recurring or chronic basis. While traditional urine testing methods only capture drug use within a window of several hours or days, hair analysis provides an extended detection window that delivers a long-term history of substance use patterns over extended periods, offering insights into ongoing drug use behaviors. \"These findings demonstrate the...",
    "product": "2026 Quest Diagnostics Drug Testing Index",
    "summary": "Quest Diagnostics released its 2026 Drug Testing Index, which found that nearly one in five U.S. workers tested positive for drug use in 2025 based on hair specimen analysis.",
    "location": "Secaucus, New Jersey, USA",
    "planning": false,
    "image_url": "https://mma.prnewswire.com/media/2691025/Quest_Diagnostics_questhealth_Logo_v1.jpg?p=facebook",
    "confidence": 0.9,
    "product_data": {
      "name": "Quest Diagnostics Drug Testing Index",
      "full_text": "the 2026 Quest Diagnostics Drug Testing Index™",
      "fuzzy_match": false
    },
    "product_tags": [
      "report",
      "data"
    ],
    "published_at": "2026-07-10T13:24:00Z",
    "location_data": [
      {
        "city": "Secaucus",
        "state": "New Jersey",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-07-10",
    "article_sentence": "Nearly one in five workers in the general U.S. workforce (19.1%) tested positive for drug use based on an analysis of hair specimens collected in 2025, an increase of nearly 46% compared to 13.1% in 2021, finds the 2026 Quest Diagnostics Drug Testing Index™."
  }
}

curl https://signals.autobound.ai/v1/signals/175b4898-1de3-9660-992b-9de3d8394b99 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"questdiagnostics.com","limit":20}'